Oct 27, 2023 / 12:00PM GMT
Marcus Wolfinger - Stratec SE - Chairman of Board of Management & CEO
Good morning in the United States. Good afternoon in Europe, ladies and gentlemen, welcome to our 9 months financial press conference. Before we start, please allow me to mention some housekeeping things. You can download that presentation from either the webcast or our website, and I think I don't need to read you through the safe harbor statement.
As always, I'm intending to fit this presentation into 3 major segments. So first of all, I would like to take an overview then talking about financial details. and then trying to give you an outlook, then we will get back to Morris who will explain us how to commence with Q&A, and that should do it. In the presentation, we have some supplementary data. So 9 months at a glance. We are actually back about 9% compared to 2022 top line comparing to a 9-month revenue volume of EUR 188 million.
The decline in performance was mainly generated by weak molecular diagnostics sales which is actually still an outcome of the overcapacity built during the pandemic, particularly
Q3 2023 Stratec SE Earnings Call Transcript
Oct 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers